γ-Glu-Tyr

CAS No. 7432-23-7

γ-Glu-Tyr( —— )

Catalog No. M37159 CAS No. 7432-23-7

γ-Glu-Tyr (gamma-Glutamyltyrosine) is a kokumi peptide with competitive inhibition of dipeptidyl peptidase-IV (DPP-IV) and is used in the study of diabetes mellitus.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 46 Get Quote
5MG 45 Get Quote
10MG 76 Get Quote
25MG 138 Get Quote
50MG 212 Get Quote
100MG 360 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    γ-Glu-Tyr
  • Note
    Research use only, not for human use.
  • Brief Description
    γ-Glu-Tyr (gamma-Glutamyltyrosine) is a kokumi peptide with competitive inhibition of dipeptidyl peptidase-IV (DPP-IV) and is used in the study of diabetes mellitus.
  • Description
    γ-Glu-Tyr, a competitive inhibitor of dipeptidyl peptidase-IV (DPP-IV) (IC50=6.77 mM), is a potentially functional component of the type 2 diabetes diet.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    7432-23-7
  • Formula Weight
    310.3
  • Molecular Formula
    C14H18N2O6
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (322.27 mM; Ultrasonic )
  • SMILES
    C([C@H](NC(CC[C@@H](C(O)=O)N)=O)C(O)=O)C1=CC=C(O)C=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Yang J, et al. γ‐Glu‐Met synthesised using a bacterial glutaminase as a potential inhibitor of dipeptidyl peptidase IV[J]. International Journal of Food Science & Technology, 2018, 53(5): 1166-1175.
molnova catalog
related products
  • Pancreatic Polypepti...

    Pancreatic Polypeptide (31-36) (free acid) (human)

  • Polylysine

    Polylysine

  • (Z)-Butylidenephthal...

    (Z)-Butylidenephthalide ((Z)-3-Butylidenephthalide) has antitumor and hypoglycemic effects, and can effectively inhibit the tumor growth of glioma and inhibit R-glucosidase activity.